IPO Is Next Finance Target For Hookipa Biotech After $60m Series C

 
• By Sten Stovall

Emerging Company Profile: Austria's privately-held Hookipa Biotech just raised $60m to progress two proof of concept clinical trials for its lead development programs. It will eventually seek a public listing.

Emerging Company Profile Regular column feature image Version 2

More from Strategy

More from Business